NIH study identifies new targets for anti-malaria drugs
Researchers have sought to uncover the role of plasmepsins IX and X, produced by P. falciparum for metabolic processes...
List view / Grid view
Researchers have sought to uncover the role of plasmepsins IX and X, produced by P. falciparum for metabolic processes...
A three-pronged antibody has been found to protect from infection with two strains of SHIV, better than individual natural antibodies...
Flow cytometry continues to evolve at a fast pace and provides neuroscientists with the ability to perform many highly-specialised assays simultaneously. It meets the demands of cutting-edge research in neuroscience that has allowed researchers to isolate particular neural cells from heterogeneous population and catalogue its molecular or physical features...
Pushpanathan Muthuirulan & Pooja Sharma explain how high-throughput next-generation sequencing (NGS) technologies are revolutionising our ability to characterise infectious diseases at genomic, transcriptomic and epigenetic levels...
Study from NIH may help improve prenatal genetic screening...
Researchers have described two structures and mechanisms - efflux pumps and reinforced cell walls - that certain disease-causing bacteria use to keep antibiotics away...
Phase 2 trial to explore targeted therapies for children with solid tumours that harbour specific genetic mutations which have progressed during or after standard therapy...
Researchers at Stanford University in Palo Alto, California, have tracked physical activity by population for more than 100 countries.
For nearly two decades researchers have sought a way to target an oestrogen receptor in the hope they could improve breast cancer survival, but an article contends that the effort may never pan out.
NIH-supported research suggests potential treatment strategy following the identification of single-gene mutations that lead to eczema.
A review of Keap1/Nrf2 modulation of ROS homeostasis, and its pivotal role in the pathogenesis of cancer, Type 2 diabetes mellitus & neurological disorders.
St. Jude Children’s Research Hospital discovery of a regulatory enzyme working at the primary cilium could lead to treatments for the brain tumour medulloblastoma.
Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design.
Researchers find key molecule that could lead to new therapies for anaemia and other iron disorders.
The science behind harnessing the immune system to fight cancer is complicated, but a University of Rochester Medical Center laboratory discovered a simple, practical way to use light and optics to steer killer immune cells toward tumours.